newsfilter
← Latest News
GlobeNewswire·

Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements

New agreement grants Terumo Virtue SAB coronary indication right of first refusal and supersedes prior distribution agreementTerumo to pay a total of $30 million to Orchestra BioMedOrchestra BioMed retains all